PROSPECTIVE-STUDY OF PROGNOSTIC FACTORS IN PATIENTS WITH UNRESECTED HEPATIC METASTASES FROM COLORECTAL-CANCER

被引:147
作者
ROUGIER, P [1 ]
MILAN, C [1 ]
LAZORTHES, F [1 ]
FOURTANIER, G [1 ]
PARTENSKY, C [1 ]
BAUMEL, H [1 ]
FAIVRE, J [1 ]
机构
[1] FDN FRANCAIS CANCEROL DIGEST,FAC MED,F-21000 DIJON,FRANCE
关键词
D O I
10.1002/bjs.1800821034
中图分类号
R61 [外科手术学];
学科分类号
摘要
Prognostic factors of unresected liver metastases in patients with colorectal cancer are not well established. A total of 544 patients with unresected liver metastases from colorectal cancer were registered in a national survey over a 1-year period and followed until death. Twenty factors were studied in a univariate analysis (log rank test) and 16 influenced survival (P<0.01). These 16 factors were entered in a multivariate analysis (Cox model) and eight, ranging from the most significant (relative risk of death 1.9) to the less significant (relative risk of death 1.2), independently influenced survival: performance status, alkaline phosphatase level, number of involved liver segments, administration of chemotherapy, presence of extrahepatic metastases, site of the primary tumour, prothrombin time and resection of the primary lesion. Two simple classifications are proposed, taking into account the performance status and the alkaline phosphatase level, or the performance status and the number of involved liver segments.
引用
收藏
页码:1397 / 1400
页数:4
相关论文
共 21 条
[11]  
KEMENY N, 1980, NEOPLASMS COLON RECT, P155
[12]   A MULTIFACTORIAL ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH LIVER METASTASES FROM COLORECTAL-CARCINOMA [J].
LAHR, CJ ;
SOONG, SJ ;
CLOUD, G ;
SMITH, JW ;
URIST, MM ;
BALCH, CM .
JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) :720-726
[13]  
NORDLINGER B, 1992, TRAITEMENT METASTASE, P141
[14]   DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].
PETO, R ;
PIKE, MC ;
ARMITAGE, P ;
BRESLOW, NE ;
COX, DR ;
HOWARD, SV ;
MANTEL, N ;
MCPHERSON, K ;
PETO, J ;
SMITH, PG .
BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39
[15]  
Pettavel J, 1978, Prog Clin Cancer, V7, P217
[16]   BIOCHEMICAL MODULATION OF FLUOROURACIL - EVIDENCE OF SIGNIFICANT IMPROVEMENT OF SURVIVAL AND QUALITY OF LIFE IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA [J].
POON, MA ;
OCONNELL, MJ ;
MOERTEL, CG ;
WIEAND, HS ;
CULLINAN, SA ;
EVERSON, LK ;
KROOK, JE ;
MAILLIARD, JA ;
LAURIE, JA ;
TSCHETTER, LK ;
WIESENFELD, M .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1407-1418
[17]   RANDOMIZED COMPARISON OF COMBINATION CHEMOTHERAPY PLUS SUPPORTIVE CARE WITH SUPPORTIVE CARE ALONE IN PATIENTS WITH METASTATIC COLORECTALCANCER [J].
SCHEITHAUER, W ;
ROSEN, H ;
KORNEK, GV ;
SEBESTA, C ;
DEPISCH, D .
BRITISH MEDICAL JOURNAL, 1993, 306 (6880) :752-755
[18]   THE NATURAL-HISTORY OF HEPATIC METASTASES FROM COLORECTAL-CANCER - A COMPARISON WITH RESECTIVE TREATMENT [J].
WAGNER, JS ;
ADSON, MA ;
VANHEERDEN, JA ;
ADSON, MH ;
ILSTRUP, DM .
ANNALS OF SURGERY, 1984, 199 (05) :502-508
[19]  
Wood C B, 1976, Clin Oncol, V2, P285
[20]  
1992, J CLIN ONCOL, V10, P904